Product Information
ROFLUMILAST 250 MCG TABLET is a generic product labeled by Micro Labs Limited, priced at $1.9069 per EA under NDC 42571036983. Its NADAC has been published 151 times since Aug 9, 2023.
Strength
250 ug/1
Manufacturer
Micro Labs LimitedNDC
42571036983
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROFLUMILASTApproval Type
Generic (ANDA)
FDA Application
ANDA208180On Market Since
5/1/2023
Pharmacological Classes
Price Statistics
The NADAC for ROFLUMILAST 250 MCG TABLET has been published 151 times since Aug 9, 2023, and over the history we have for it it has declined 76.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9069 per EA |
|---|---|
| All-time high | $8.0346 (Aug 16, 2023) |
| All-time low | $1.5913 (Jul 17, 2024) |
| 52-week high | $2.4855 |
| 52-week low | $1.9069 |
| Median price | $2.3966 |
| Average price | $2.6571 |
| Largest weekly change | +63.4% (Aug 21, 2024) |
| Weeks tracked | 151 |
| Tracking since | Aug 9, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ROFLUMILAST market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ROFLUMILAST 250 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROFLUMILAST 250 MCG TABLET, manufactured by Micro Labs Limited, is $1.9069 per EA (NDC 42571036983), effective Jun 24, 2026.
How has the price of ROFLUMILAST 250 MCG TABLET changed over time?
Over the history we have for it, the NADAC for ROFLUMILAST 250 MCG TABLET has declined 76.3%. It has been tracked across 151 weekly CMS publications since Aug 9, 2023.
What are the highest and lowest recorded NADAC prices for ROFLUMILAST 250 MCG TABLET?
Since Aug 9, 2023, the NADAC for ROFLUMILAST 250 MCG TABLET has ranged from a low of $1.5913 (Jul 17, 2024) to a high of $8.0346 (Aug 16, 2023), with a median of $2.3966 per EA.
Are there cheaper alternatives to ROFLUMILAST 250 MCG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ROFLUMILAST 250 MCG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ROFLUMILAST 250 MCG TABLET?
ROFLUMILAST 250 MCG TABLET (NDC 42571036983) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification